The start-up aims to use AI to drastically reduce the time and money it takes to develop new drugs. View on euronews ...

Artificial intelligence (AI) helped develop Pirelli's tires of the future, its new-generation P Zero product line, in record ...

Startup Persist AI, which launched a cloud lab to accelerate pharmaceutical formulation development, raised $12 million in a ...

AI adoption in pharma can be slow, but failing to scale these new tools across your organization is a missed opportunity.

The pharmaceutical industry has long touted the promise of AI in slashing time and costs in the research and development ...

Not unlike Regeneron's acquisition of 23andMe, Predictive Oncology's AI-driven breakthroughs reflect a broader transformation ...

SACRAMENTO, Calif., May 19, 2025 /PRNewswire/ -- Persist AI, a pioneer in AI-driven robotics for pharmaceutical formulation development and Chemistry, Manufacturing, and Controls (CMC), today ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer.

Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.

Last year, Lonza, a Swiss CDMO, initiated an AI-enabled route scouting program to identify new methods for synthesizing novel molecules that avoid manufacturing bottlenecks and speed drug ...

Boehringer Ingelheim has entered a multi-year partnership with Tempus AI to progress its cancer treatment pipeline.

The funding round was led by Spero Ventures with participation from MBX Capital, Shimadzu Future Innovation Fund managed by Global Brain Corporation, Eli Lilly & Company, SignalFire, Ford Street ...